Core Technology

ENERGI-F705  (Parkinson's Disease Control)

Deficient mitochondria is widely regarded to be closely associated with brain neurodegenerative disease, especially Parkinson's disease, since mitochondria is a factory of cellular energy, capable of providing energy molecule ATP to meet various physiological and biochemical needs of cells.

According to nerve cell test by Energenesis Biomedical team, ENEGI-F705 is proven to be capable of increasing ATP in nerve cells. Long-term feeding of ENERGI-F705 to animals can increase the number of mitochondria in nerve microglia and cellular ATP via adjusting AMPK/PGC-alpha in cells. Evaluation on the development of clinical medicines has begun.